Search

The carbon dioxide laser has been found to be a useful surgical adjuvant in our efforts to treat carcinoma and benign tumors of the head and neck. It has been of help in establishing the proper staging, in diagnosing recurrence after radiation therapy, in re-establishing the airway blocked by tumor, and in reducing tumor mass prior to definitive therapy. It provides a simple method of excision for curative therapy. All of this is accomplished with minimal morbidity. Most patients can return home on the first postoperative day. They can eat, have a serviceable voice, and require no tracheotomy or analgesics, all of which provide a significant cost benefit.

Endoscopic treatment of early carcinoma of the larynx is curative, the cure rates in our experience being equal to those achieved by radiation therapy and by laryngofissure. It is highly cost effective in terms of money and of patient out-of-work time. It can be used repeatedly and does not interfere with future treatments. It is our method of choice.

The work-up of any patient with cancer in the head and neck area reveals that each is unique. Treatment planning must respect this. A "team" that embodies the attributes of such a group is necessary to uncover the multitude of facts, to formulate a plan of management, and to carry out treatment successfully.

Medical management of organic laryngeal disorders always involves evaluation and advice; it frequently includes reassurance and sometimes voice therapy. Occasionally medication is also necessary.